Reports

Sale

Global Pharmacovigilance and Drug Safety Software Market: By Functionality: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software; By Mode of Delivery: On-Premises Delivery, On-Demand/Cloud Based (SaaS) Delivery; By End User; Regional Analysis; Supplier Landscape; 2024-2032

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1   Preface
   1.1   Objectives of the Study
   1.2   Key Assumptions
   1.3   Report Coverage – Key Segmentation and Scope
   1.4   Research Methodology
2   Executive Summary
3   Global Pharmacovigilance and Drug Safety Software Market Overview
   3.1   Global Pharmacovigilance and Drug Safety Software Market Historical Value (2017-2023)
   3.2   Global Pharmacovigilance and Drug Safety Software Market Forecast Value (2024-2032)
4   Global Pharmacovigilance and Drug Safety Software Market Landscape
   4.1   Global Pharmacovigilance and Drug Safety Software Developers Landscape
       4.1.1   Analysis by Year of Establishment
       4.1.2   Analysis by Company Size
       4.1.3   Analysis by Region
   4.2   Global Pharmacovigilance and Drug Safety Software Product Landscape
       4.2.1   Analysis by Functionality
       4.2.2   Analysis by Mode of Mode of Delivery
       4.2.3   Analysis by End User
5   Global Pharmacovigilance and Drug Safety Software Market Dynamics
   5.1   Market Drivers and Constraints
   5.2   SWOT Analysis
   5.3   Porter’s Five Forces Model
   5.4   Key Demand Indicators
   5.5   Key Price Indicators
   5.6   Industry Events, Initiatives, and Trends
   5.7   Value Chain Analysis
6   Global Pharmacovigilance and Drug Safety Software Market Segmentation
   6.1   Global Pharmacovigilance and Drug Safety Software Market by Functionality
       6.1.1   Market Overview
       6.1.2   Adverse Event Reporting Software
       6.1.3   Drug Safety Audits Software
       6.1.4   Issue Tracking Software
       6.1.5   Fully Integrated Software
   6.2   Global Pharmacovigilance and Drug Safety Software Market by Mode of Delivery
       6.2.1   Market Overview
       6.2.2   On-Premises Delivery
       6.2.3   On-Demand/Cloud Based (SaaS) Delivery
   6.3   Global Pharmacovigilance and Drug Safety Software Market by End User
       6.3.1   Market Overview
       6.3.2   Pharma and Biotech Companies
       6.3.3   Contract Research Organizations (CROs)
       6.3.4   Business Process Outsourcing (BPO) Firms
       6.3.5   Others
   6.4   Global Pharmacovigilance and Drug Safety Software Market by Region
       6.4.1   Market Overview
       6.4.2   North America
       6.4.3   Europe
       6.4.4   Asia Pacific
       6.4.5   Latin America
       6.4.6   Middle East and Africa
7   North America Pharmacovigilance and Drug Safety Software Market
   7.1   Market Share by Country
   7.2   United States of America
   7.3   Canada
8   Europe Pharmacovigilance and Drug Safety Software Market
   8.1   Market Share by Country
   8.2   United Kingdom
   8.3   Germany
   8.4   France
   8.5   Italy
   8.6   Others
9   Asia Pacific Pharmacovigilance and Drug Safety Software Market
   9.1   Market Share by Country
   9.2   China
   9.3   Japan
   9.4   India
   9.5   ASEAN
   9.6   Australia
   9.7   Others
10   Latin America Pharmacovigilance and Drug Safety Software Market
   10.1   Market Share by Country
   10.2   Brazil
   10.3   Argentina
   10.4   Mexico
   10.5   Others
11   Middle East and Africa Pharmacovigilance and Drug Safety Software Market
   11.1   Market Share by Country
   11.2   Saudi Arabia
   11.3   United Arab Emirates
   11.4   Nigeria
   11.5   South Africa
   11.6   Others
12   Patent Analysis
   12.1   Analysis by Type of Patent
   12.2   Analysis by Publication year
   12.3   Analysis by Issuing Authority
   12.4   Analysis by Patent Age
   12.5   Analysis by CPC Analysis
   12.6   Analysis by Patent Valuation
   12.7   Analysis by Key Players
13   Grants Analysis
   13.1   Analysis by year
   13.2   Analysis by Amount Awarded
   13.3   Analysis by Issuing Authority
   13.4   Analysis by Grant Application
   13.5   Analysis by Funding Institute
   13.6   Analysis by NIH Departments
   13.7   Analysis by Recipient Organization
14   Funding Analysis
   14.1   Analysis by Funding Instances
   14.2   Analysis by Type of Funding
   14.3   Analysis by Funding Amount
   14.4   Analysis by Leading Players
   14.5   Analysis by Leading Investors
   14.6   Analysis by Geography
15   Partnership and Collaborations Analysis
   15.1   Analysis by Partnership Instances
   15.2   Analysis by Type of Partnership
   15.3   Analysis by Leading Players
   15.4   Analysis by Geography
16   Regulatory Framework
   16.1   Regulatory Overview
       16.1.1   US FDA
       16.1.2   EU EMA
       16.1.3   INDIA CDSCO
       16.1.4   JAPAN PMDA
       16.1.5   Others
17   Supplier Landscape
   17.1   IQVIA
       17.1.1   Financial Analysis
       17.1.2   Product Portfolio
       17.1.3   Demographic Reach and Achievements
       17.1.4   Mergers and Acquisitions
       17.1.5   Certifications
   17.2   Accenture
       17.2.1   Financial Analysis
       17.2.2   Product Portfolio
       17.2.3   Demographic Reach and Achievements
       17.2.4   Mergers and Acquisitions
       17.2.5   Certifications
   17.3   Cognizant
       17.3.1   Financial Analysis
       17.3.2   Product Portfolio
       17.3.3   Demographic Reach and Achievements
       17.3.4   Mergers and Acquisitions
       17.3.5   Certifications
   17.4   Laboratory Corporation of America Holdings
       17.4.1   Financial Analysis
       17.4.2   Product Portfolio
       17.4.3   Demographic Reach and Achievements
       17.4.4   Mergers and Acquisitions
       17.4.5   Certifications
   17.5   IBM
       17.5.1   Financial Analysis
       17.5.2   Product Portfolio
       17.5.3   Demographic Reach and Achievements
       17.5.4   Mergers and Acquisitions
       17.5.5   Certifications
   17.6   ARIS Global
       17.6.1   Financial Analysis
       17.6.2   Product Portfolio
       17.6.3   Demographic Reach and Achievements
       17.6.4   Mergers and Acquisitions
       17.6.5   Certifications
   17.7   ICON Plc.
       17.7.1   Financial Analysis
       17.7.2   Product Portfolio
       17.7.3   Demographic Reach and Achievements
       17.7.4   Mergers and Acquisitions
       17.7.5   Certifications
   17.8   Capgemini
       17.8.1   Financial Analysis
       17.8.2   Product Portfolio
       17.8.3   Demographic Reach and Achievements
       17.8.4   Mergers and Acquisitions
       17.8.5   Certifications
   17.9   Oracle
       17.9.1   Financial Analysis
       17.9.2   Product Portfolio
       17.9.3   Demographic Reach and Achievements
       17.9.4   Mergers and Acquisitions
       17.9.5   Certifications
   17.10   Parexel International Corporation
       17.10.1   Financial Analysis
       17.10.2   Product Portfolio
       17.10.3   Demographic Reach and Achievements
       17.10.4   Mergers and Acquisitions
       17.10.5   Certifications
   17.11   Ab Cube
       17.11.1   Financial Analysis
       17.11.2   Product Portfolio
       17.11.3   Demographic Reach and Achievements
       17.11.4   Mergers and Acquisitions
       17.11.5   Certifications
   17.12   Extedo GmbH
       17.12.1   Financial Analysis
       17.12.2   Product Portfolio
       17.12.3   Demographic Reach and Achievements
       17.12.4   Mergers and Acquisitions
       17.12.5   Certifications
   17.13   Ennov Solutions Inc.
       17.13.1   Financial Analysis
       17.13.2   Product Portfolio
       17.13.3   Demographic Reach and Achievements
       17.13.4   Mergers and Acquisitions
       17.13.5   Certifications
18   Global Pharmacovigilance and Drug Safety Software Market - Distribution Model (Additional Insight)
   18.1   Overview
   18.2   Potential Distributors
   18.3   Key Parameters for Distribution Partner Assessment
19   Key Opinion Leaders (KOL) Insights (Additional Insight)
20   Company Competitiveness Analysis (Additional Insight)
   20.1   Very Small Companies
   20.2   Small Companies
   20.3   Mid-Sized Companies
   20.4   Large Companies
   20.5   Very Large Companies
21   Payment Methods (Additional Insight)
   21.1   Government Funded
   21.2   Private Insurance
   21.3   Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

What is the growth rate of the market?

The global pharmacovigilance and drug safety software market is estimated to witness a healthy growth, expanding at a CAGR of 9% in the forecast period of 2024-2032.

What are the major industry drivers?

The major drivers of the market include the increasing incidences of ADR (adverse drug reaction) and the growing adoption of interconnected software services by several outsourcing businesses.

What are the key industry trends of the global pharmacovigilance and drug safety software market?

The increasing demand for different drugs and medicines worldwide and ongoing attempts to improve access to safe and effective drugs are expected to be the key trends guiding the growth of the industry.

What are the major regional markets of pharmacovigilance and drug safety software, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the major functionalities of the product in which the market is divided into?

Drug safety audits software, adverse event reporting software, issue tracking software, and fully integrated software are the major functionalities of the product.

What are the different modes of delivery of the product in the market?

On-premise delivery and on-demand/ cloud-based (SaaS) delivery are the different delivery modes of the product in the market.

What are the significant end uses of the product in the market?

Pharma and biotech companies, contract research organisations (CROs), and business process outsourcing (BPO) firms, among others are the significant end uses of the product in the market.

Who are the key industry players, according to the report?

The major players in the industry are ArisGlobal, Ennov Solutions Inc., EXTEDO GmbH, Oracle Corporation, Sparta Systems, Inc., United BioSource Corporation, AB Cube, Others.

Request Sample

Purchase Full Report

Datasheet

$ ~~2969~~ $2699

Selected Sections, One User
Printing Not Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Single User License

$ ~~5499~~ $4999

All Sections, One User
One Print Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Five User License

$ ~~6599~~ $5999

All Sections, Five Users
Five Prints Allowed
Email Delivery in PDF
Free Limited Customisation
Post Sales Analyst Support
~~50% Discount on Next Update~~

Buy Now

Corporate License

$ ~~7699~~ $6999

All Sections, Unlimited Users
Unlimited Prints Allowed
Email Delivery in PDF + Excel
Free Limited Customisation
Post Sales Analyst Support
50% Discount on Next Update

Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER